rs1554429221
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_015450.3(POT1):c.126T>G(p.Asp42Glu) variant causes a missense, splice region change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_015450.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POT1 | NM_015450.3 | c.126T>G | p.Asp42Glu | missense_variant, splice_region_variant | Exon 7 of 19 | ENST00000357628.8 | NP_056265.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Tumor predisposition syndrome 3 Pathogenic:1
This sequence change replaces aspartic acid, which is acidic and polar, with glutamic acid, which is acidic and polar, at codon 42 of the POT1 protein (p.Asp42Glu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with POT1-related conditions (Invitae; external communication). ClinVar contains an entry for this variant (Variation ID: 475035). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. RNA analysis provides insufficient evidence to determine the effect of this variant on POT1 splicing (Invitae). For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.D42E variant (also known as c.126T>G), located in coding exon 3 of the POT1 gene, results from a T to G substitution at nucleotide position 126. The aspartic acid at codon 42 is replaced by glutamic acid, an amino acid with highly similar properties. This alteration has been observed in multiple individuals with a personal and/or family history that is consistent with POT1-related disease and was shown to segregate with disease in at least one family (Ambry internal data). This amino acid position is highly conserved in available vertebrate species. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at